US Stock MarketDetailed Quotes
CSBR Champions Oncology
- 4.770
- -0.250-4.98%
Close Apr 29 16:00 ET
64.84MMarket Cap-6625P/E (TTM)
4.920High4.740Low4.63KVolume4.900Open5.020Pre Close22.29KTurnover0.10%Turnover RatioLossP/E (Static)13.59MShares7.32052wk High-31.59P/B22.52MFloat Cap4.17052wk Low--Dividend TTM4.72MShs Float25.800Historical High--Div YieldTTM3.59%Amplitude0.072Historical Low4.815Avg Price1Lot Size
Champions Oncology Key Stats
Quarterly+Annual
YOY
| (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | (FY)Apr 30, 2022 | (Q4)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -158.42%-919K | -82.08%589K | -1,946.67%-3.99M | -38.86%3.97M | -186.93%-692K | -63.05%1.57M | 167.59%3.29M | -190.28%-195K | 486.50%6.5M | 140.20%796K |
| Net income from continuing operations | -3.73%-2.53M | -12,843.75%-2.07M | -704.39%-2.57M | -1,073.54%-5.34M | -644.48%-2.56M | -409.91%-2.44M | -105.78%-16K | -85.47%-319K | 51.38%548K | 48.89%-344K |
| Operating gains losses | --16K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4K | --0 |
| Depreciation and amortization | -16.35%481K | -13.57%484K | -15.72%445K | 38.05%2.25M | 2.64%583K | 45.20%575K | 61.85%560K | 66.56%528K | 37.42%1.63M | 87.46%568K |
| Other non cash items | 1.82%280K | -15.02%232K | 0.37%270K | 21.12%952K | -46.22%135K | 1,618.75%275K | -0.36%273K | 9.80%269K | 143.34%786K | 45.93%251K |
| Change In working capital | -86.97%375K | -20.99%1.75M | -210.01%-2.73M | 81.64%4.24M | 157.14%24K | 4.73%2.88M | 1,305.06%2.22M | -66.48%-879K | 155.66%2.34M | 97.84%-42K |
| -Change in receivables | -126.51%-250K | 317.39%1.15M | -795.57%-1.1M | 146.42%1.31M | 93.87%-69K | 353.49%943K | 155.65%276K | 119.15%158K | -24.42%-2.82M | -30.21%-1.13M |
| -Change in prepaid assets | -131.98%-55K | 162.10%325K | 19.89%223K | 1.60%-184K | -14.04%-666K | 0.58%172K | -6.77%124K | 100.00%186K | 67.31%-187K | -8.55%-584K |
| -Change in payables and accrued expense | 1,083.02%627K | -172.49%-1.29M | 131.26%246K | 100.52%2.32M | 410.49%1.27M | -86.09%53K | 2,682.81%1.78M | -170.14%-787K | 174.07%1.16M | -811.11%-410K |
| -Change in other current assets | ---1K | --0 | ---169K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in other current liabilities | -16.67%-308K | 1.53%-257K | -16.80%-292K | -43.74%-907K | 54.95%-132K | -26,300.00%-264K | 1.14%-261K | -242.47%-250K | -164.02%-631K | -115.44%-293K |
| -Change in other working capital | -81.66%362K | 508.33%1.83M | -778.49%-1.63M | -64.57%1.71M | -116.12%-382K | -23.16%1.97M | -53.92%300K | 76.00%-186K | 991.84%4.82M | 758.33%2.37M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -158.42%-919K | -82.08%589K | -1,946.67%-3.99M | -38.86%3.97M | -186.93%-692K | -63.05%1.57M | 167.59%3.29M | -190.28%-195K | 486.50%6.5M | 140.20%796K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 83.29%-126K | 74.67%-153K | 11.41%-668K | -20.47%-2.87M | -50.20%-760K | -86.17%-754K | -6.71%-604K | 16.87%-754K | 24.77%-2.38M | 39.33%-506K |
| Net PPE purchase and sale | 83.29%-126K | 74.67%-153K | 11.41%-668K | -20.47%-2.87M | -50.20%-760K | -86.17%-754K | -6.71%-604K | 16.87%-754K | 27.34%-2.38M | 40.75%-506K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 83.29%-126K | 74.67%-153K | 11.41%-668K | -20.47%-2.87M | -50.20%-760K | -86.17%-754K | -6.71%-604K | 16.87%-754K | 24.77%-2.38M | 39.33%-506K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 141.86%208K | -590K | -94.69%11K | -568.75%-75K | 0 | -28.93%86K | 0 | -82.68%207K | -77.78%16K |
| Net common stock issuance | --0 | ---32K | ---602K | ---74K | ---74K | --0 | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | --0 | 179.07%240K | --12K | -58.94%85K | -106.25%-1K | --0 | -28.93%86K | --0 | -84.88%207K | -78.08%16K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 141.86%208K | ---590K | -94.69%11K | -568.75%-75K | --0 | -28.93%86K | --0 | -82.68%207K | -77.78%16K |
| Net cash flow | ||||||||||
| Beginning cash position | -49.08%5.51M | -39.58%4.87M | 12.33%10.12M | 92.17%9.01M | 33.84%11.65M | 126.44%10.83M | 101.55%8.06M | 92.17%9.01M | -43.81%4.69M | 17.12%8.7M |
| Current changes in cash | -227.59%-1.05M | -76.73%644K | -453.11%-5.25M | -74.28%1.11M | -599.02%-1.53M | -79.11%819K | 253.51%2.77M | -37.74%-949K | 218.19%4.32M | 111.16%306K |
| End cash Position | -61.63%4.47M | -49.08%5.51M | -39.58%4.87M | 12.33%10.12M | 12.33%10.12M | 33.84%11.65M | 126.44%10.83M | 101.55%8.06M | 92.17%9.01M | 92.17%9.01M |
| Free cash flow | -227.59%-1.05M | -83.74%436K | -390.94%-4.66M | -73.26%1.1M | -600.69%-1.45M | -78.74%819K | 305.14%2.68M | -37.34%-949K | 182.89%4.11M | 110.23%290K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg